EP 0863902 A1 19980916 - 2'-¬¬4'-HALO-¬1,1'-BIPHENYL -4-YL METHYL -5'-METHYL-SPIRO¬CYCLOPENTANE-1,7'(8'H)-¬3H IMIDAZO¬2,1-b PURIN -4'(5'H)-ONES
Title (en)
2'-¬¬4'-HALO-¬1,1'-BIPHENYL -4-YL METHYL -5'-METHYL-SPIRO¬CYCLOPENTANE-1,7'(8'H)-¬3H IMIDAZO¬2,1-b PURIN -4'(5'H)-ONES
Title (de)
2'-¬¬4'-HALO-¬1,1'-BIPHENYL -4-YL METHYL -5'-METHYL-SPIRO¬CYCLOPENTANE-1,7'(8'H)-¬3H IMIDAZO¬2,1-b PURIN -4'(5'H)-ONE
Title (fr)
COMPOSES 2'-¬¬4'-HALO-¬1,1'-BIPHENYL -4-YL METHYL -5'-METHYL-SPIRO¬CYCLOPENTANE-1,7'(8'H)-¬3H IMIDAZO¬2,1-b PURIN -4'(5'H)-ONES
Publication
Application
Priority
- US 9618550 W 19961126
- US 56371795 A 19951128
Abstract (en)
[origin: WO9719947A1] Antihypertensive and bronchodilating compounds of formula (I) or a pharmaceutically acceptable salt thereof wherein X is fluoro, chloro or bromo.
IPC 1-7
IPC 8 full level
A61K 31/00 (2006.01); A61K 31/52 (2006.01); A61K 31/522 (2006.01); A61P 5/34 (2006.01); A61P 5/36 (2006.01); A61P 5/38 (2006.01); A61P 5/42 (2006.01); A61P 7/00 (2006.01); A61P 7/02 (2006.01); A61P 11/00 (2006.01); A61P 11/08 (2006.01); A61P 43/00 (2006.01); C07D 487/20 (2006.01)
CPC (source: EP)
A61P 5/34 (2017.12); A61P 5/36 (2017.12); A61P 5/38 (2017.12); A61P 5/42 (2017.12); A61P 7/00 (2017.12); A61P 7/02 (2017.12); A61P 11/00 (2017.12); A61P 11/08 (2017.12); A61P 43/00 (2017.12); C07D 487/20 (2013.01)
Citation (search report)
See references of WO 9719947A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
Designated extension state (EPC)
LT LV RO
DOCDB simple family (publication)
WO 9719947 A1 19970605; AR 004752 A1 19990310; AU 1055597 A 19970619; CA 2237956 A1 19970605; CO 4480029 A1 19970709; EP 0863902 A1 19980916; JP 2000501095 A 20000202; MX 9804198 A 19981031; ZA 969888 B 19970526
DOCDB simple family (application)
US 9618550 W 19961126; AR P960105319 A 19961125; AU 1055597 A 19961126; CA 2237956 A 19961126; CO 96062218 A 19961126; EP 96941401 A 19961126; JP 52054397 A 19961126; MX 9804198 A 19980527; ZA 969888 A 19961125